Epidemiological Study of Lung Cancer and Clinical Medication in England from 2001 to 2019.
Epidemiological Study of Lung Cancer and Clinical Medication in England from 2001 to 2019.
复制标题
DOI：
10.1155/2022/3577312
复制
发表时间：
2022
影响因子：
--
通讯作者：
Yang Y
中科院分区：
文献类型：
--
作者：
Zhang B;Yang Y
我们的目的是探讨2001年至2019年英国肺癌的流行病学特征和变化以及临床用药。我们使用MEDLINE、PubMed和PsychINFO等搜索引擎系统检索相关研究。肺癌是一种严重的疾病，预后通常很差。从2001年到2019年，英格兰的肺癌总体死亡率逐年下降，但男性、老年人以及暴露在污染空气中的人群仍更容易感染肺癌或因此死亡，英格兰北部的肺癌患病率和死亡率明显高于南部，且差距逐年加大。肺癌具有可变的危险因素，如戒烟和改善空气质量，可以有效降低相关风险。紫杉醇、多西他赛、吉西他滨和长春瑞滨是英国治疗肺癌的主要药物，这些药物的治疗有利于患者的生存和生活质量。男性和老年人是肺癌的高发人群，这意味着肺癌具有明显的性别不平等和年龄不平等。同时，基于不同地区肺癌风险的统计数据，可以得出肺癌也具有较强的地域和经济不平等性。改变危险因素和使用药物可以有效降低肺癌的风险，并提供有效的治疗。
We aimed to explore the epidemiological characteristics and changes of lung cancer and the clinical medication in England from 2001 to 2019. We searched related research using search engine systems such as MEDLINE, PubMed, and PsychINFO. Lung cancer is a serious disease and the prognosis is usually very poor. The overall mortality rate of lung cancer decreased year by year in England from 2001 to 2019, but men, the elderly, and people exposed to polluted air are still more likely to be infected with lung cancer or die as a result, the prevalence and mortality rate of lung cancer in the north of England is significantly higher than that in the south, and the gap is increasing year by year. Lung cancer has changeable risk factors such as quitting smoking and improving air quality, which can effectively reduce the related risk. Paclitaxel, docetaxel, gemcitabine, and vinorelbine are the main drugs for the treatment of lung cancer in England and the treatment of these drugs is beneficial to the survival and quality of life of patients. Men and the elderly are at high risk of lung cancer, which means that lung cancer has obvious gender inequality and age inequality. At the same time, based on the statistical data of lung cancer risk in different regions, it can be concluded that lung cancer also has strong geographical and economic inequality. Changing risk factors and using drugs can effectively reduce the risk of lung cancer and provide effective treatment.
登录
查看更多内容
影响因子：
168.9
作者：
Pirie, Kirstin;Peto, Richard;Beral, Valerie
通讯作者：
Beral, Valerie
影响因子：
8.8
作者：
Darby, S;Whitley, E;Doll, R
通讯作者：
Doll, R
影响因子：
10.3
作者：
Ranson, M;Davidson, N;Thatcher, N
通讯作者：
Thatcher, N
影响因子：
8.8
作者：
Baldini, E;Tibaldi, C;Rosso, R
通讯作者：
Rosso, R
影响因子：
8.8
作者：
通讯作者：
--